Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1965 1
1968 3
1969 2
1971 2
1973 2
1976 1
1986 1
1990 1
1993 1
1997 2
1998 2
1999 2
2000 1
2001 2
2002 2
2003 3
2004 2
2005 1
2006 1
2007 4
2008 3
2009 4
2010 1
2011 3
2012 9
2013 7
2014 6
2015 3
2016 6
2017 6
2018 14
2019 7
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
Hess DA, et al. Cell Metab 2019. PMID 31477497
Hess et al. quantified circulating aldehyde dehydrogenase-expressing (ALDH(hi)) cell subsets in people with T2DM given either empagliflozin (EMPA) or placebo. ...
Hess et al. quantified circulating aldehyde dehydrogenase-expressing (ALDH(hi)) cell subsets in people with T2DM given either empagli
99 results
Jump to page
Feedback